Lung cancer is also classified based on the driver oncogenic mutation such as EGFR (epidermal growth factor receptor) mutation (20%), ALK (anaplastic lymphoma kinase) rearrangement (<5%), KRAS (20%) and p53 mutations (50%) [88]. The gene discussed is EGFR; the disease is lung carcinoma.